Literature DB >> 1913410

Neuroleptic malignant syndrome without the use of neuroleptics.

D Heyland1, M Sauvé.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913410      PMCID: PMC1335901     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  15 in total

1.  Stereotyped hyperactivity in rats treated with tranylcypromine and specific inhibitors of 5-HT reuptake.

Authors:  R B Holman; E Seagraves; G R Elliott; J D Barchas
Journal:  Behav Biol       Date:  1976-04

2.  Malignant hyperpyrexia syndrome in combined treatment.

Authors:  E F Staufenberg; D Tantam
Journal:  Br J Psychiatry       Date:  1989-04       Impact factor: 9.319

3.  Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.

Authors:  S S Kline; L S Mauro; D M Scala-Barnett; D Zick
Journal:  Clin Pharm       Date:  1989-07

4.  'Neuroleptic malignant syndrome' without neuroleptics.

Authors:  D Brennan; M MacManus; J Howe; J McLoughlin
Journal:  Br J Psychiatry       Date:  1988-04       Impact factor: 9.319

Review 5.  Current concepts. Neuroleptic malignant syndrome.

Authors:  B H Guzé; L R Baxter
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

6.  Possible development of the serotonin syndrome in man.

Authors:  T R Insel; B F Roy; R M Cohen; D L Murphy
Journal:  Am J Psychiatry       Date:  1982-07       Impact factor: 18.112

7.  The combined use of MAOIs and tricyclics.

Authors:  K White; G Simpson
Journal:  J Clin Psychiatry       Date:  1984-07       Impact factor: 4.384

8.  The problems of safety and compliance with conventional antidepressant drugs.

Authors:  M Lader
Journal:  Acta Psychiatr Scand Suppl       Date:  1983

9.  The neuroleptic malignant syndrome.

Authors:  S N Caroff
Journal:  J Clin Psychiatry       Date:  1980-03       Impact factor: 4.384

10.  Interactions between relatively selective monoamine oxidase inhibitors and an inhibitor of 5-hydroxytryptamine re-uptake, clomipramine.

Authors:  E Marley; K M Wozniak
Journal:  J Psychiatr Res       Date:  1985       Impact factor: 4.791

View more
  4 in total

Review 1.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

2.  Neuroleptic malignant syndrome: a review for neurohospitalists.

Authors:  Brian D Berman
Journal:  Neurohospitalist       Date:  2011-01

Review 3.  Antipsychotic dose escalation as a trigger for neuroleptic malignant syndrome (NMS): literature review and case series report.

Authors:  Julie Langan; Daniel Martin; Polash Shajahan; Daniel J Smith
Journal:  BMC Psychiatry       Date:  2012-11-29       Impact factor: 3.630

4.  Status Epilepticus as an Unusual Manifestation of Heat Stroke.

Authors:  Won Gu Lee; So-Young Huh; Jin-Hyung Lee; Bong Goo Yoo; Meyung Kug Kim
Journal:  J Epilepsy Res       Date:  2017-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.